Cephalexin is not considered a good first-line antibiotic for sinus infections by current clinical guidelines, and most infectious disease specialists would choose a different drug. The main problem is its spectrum: cephalexin is a first-generation cephalosporin that works well against many gram-positive bacteria but has limited activity against two of the gram-negative organisms most commonly found in infected sinuses. That gap matters enough that major guideline panels leave cephalexin off their recommended lists entirely, favoring amoxicillin, amoxicillin-clavulanate, and specific second- or third-generation cephalosporins instead.
Why Cephalexin Falls Short Against Sinus Pathogens
The bacteria that cause most cases of acute bacterial sinusitis are Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes.1PubMed. Microbiology of sinusitis Cephalexin handles the two streptococcal species reasonably well because they are gram-positive cocci, and that is where first-generation cephalosporins excel. The trouble is with the other two. H. influenzae and M. catarrhalis are gram-negative organisms, and cephalexin’s activity against gram-negative bacteria drops off sharply compared to later-generation cephalosporins. In practice, prescribing cephalexin for a sinus infection means you are leaving roughly half of the likely bacterial culprits inadequately covered.
There is also the issue of beta-lactamase production. Many strains of H. influenzae and nearly all strains of M. catarrhalis produce beta-lactamase, an enzyme that chews up certain antibiotics before they can work. Beta-lactamase-producing bacteria can even shield other susceptible bacteria in the same infection, making treatment harder.2PubMed. Cephalosporins in overcoming beta-lactamase-producing bacteria and preservation of the interfering bacteria in the treatment of otitis, sinusitis and tonsillitis While cephalexin is technically stable against some beta-lactamases, the bigger problem remains its weak gram-negative coverage in the first place.
What the Guidelines Actually Recommend
The Infectious Diseases Society of America (IDSA) guidelines for acute bacterial sinusitis recommend amoxicillin-clavulanate as the preferred first-line antibiotic for both adults and children.3PubMed. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults The clavulanate component specifically addresses those beta-lactamase-producing organisms, giving the drug a much broader reach than plain amoxicillin. High-dose amoxicillin alone is sometimes used as an alternative, particularly in areas where resistance rates are low.
For people with penicillin allergies, guideline panels typically recommend second- or third-generation cephalosporins like cefuroxime, cefpodoxime, or cefdinir.4PubMed. Beginning antibiotics for acute rhinosinusitis and choosing the right treatment These drugs retain solid gram-positive coverage while adding the gram-negative activity that cephalexin lacks. For patients with serious beta-lactam allergies who cannot take any cephalosporin, macrolides like azithromycin or clarithromycin are sometimes prescribed, though bacteriologic failure rates with those drugs can run around 20 to 25 percent.5PubMed. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis Notice that even in the penicillin-allergic category, cephalexin does not appear on these lists. The cephalosporins that do appear are all second- or third-generation, with deliberately broader spectrums.
The Older Evidence That Sometimes Gets Cited
If you search for cephalexin and sinusitis, you may come across a 1985 study of acute and chronic maxillary sinusitis that reported favorable results. That study found many common sinus pathogens were resistant to other frequently prescribed antibiotics of the era but did not show resistance to cephalexin.6PubMed. Cephalexin in the treatment of acute and chronic maxillary sinusitis A separate study confirmed that cephalexin does reach concentrations in sinus mucosa that are effective against most gram-positive cocci.7PubMed. Concentration of cephalexin in maxillary sinus mucosa and secretion
These findings are not wrong, but they have to be understood in context. The 1985 study predates decades of shifting resistance patterns, and its results primarily reflect activity against gram-positive organisms. The sinus tissue penetration data similarly shows good mucosal concentrations, but concentration alone does not help if the drug does not cover the bug causing the infection. These older results explain why a doctor in the 1980s might have reasonably reached for cephalexin; they do not support the same choice today given what we now know about the mixed gram-positive and gram-negative microbiology of sinusitis and the availability of better-matched drugs.
The Dosing Problem
Even setting aside the spectrum gap, cephalexin has a practical disadvantage: it needs to be taken three to four times a day. A study comparing cephalexin to the related drug cefadroxil in pediatric respiratory infections found that cephalexin at 50 mg/kg per day divided into four doses achieved only a 75 percent cure rate, while the same total dose given four times daily at the higher 100 mg/kg level reached 100 percent. Meanwhile, cefadroxil given just twice daily at 50 mg/kg achieved a 93 percent cure rate.8Oxford Academic (Journal of Antimicrobial Chemotherapy). Comparison of twice-daily cefadroxil with four-times-daily cephalexin in paediatric respiratory infections Taking a medication four times a day is hard for most people to maintain, and missed doses undermine the drug’s effectiveness. Recommended sinus infection antibiotics like amoxicillin-clavulanate are typically dosed twice daily, and some alternatives are once daily, making adherence much easier.
Do You Even Need an Antibiotic?
Before worrying about which antibiotic to take, it is worth asking whether you need one at all. Sinus infections are self-limited in roughly 40 to 50 percent of cases, meaning they resolve on their own without any antibiotic treatment.9American family physician. Acute sinusitis: A cost-effective approach to diagnosis and treatment The vast majority of sinus infections start as viral upper respiratory infections, the common cold, and most never progress to a true bacterial infection.
Clinical guidelines emphasize distinguishing bacterial sinusitis from the viral kind before starting antibiotics. A clinician should suspect bacterial sinusitis when symptoms persist for 10 days or more beyond the onset of a cold without improvement, or when symptoms initially improve and then worsen again within 10 days, a pattern sometimes called “double worsening.”10PubMed. Clinical practice guideline: adult sinusitis Green or yellow nasal discharge alone is not a reliable indicator; some research has found that the absence of green discharge and the absence of sleep disturbance point more toward a plain viral infection.11PubMed Central. Signs and Symptoms that Diagnose Acute Sinusitis from Viral Upper Respiratory Tract Infection The color of your mucus reflects your immune system’s activity, not the presence of bacteria specifically.
Antibiotic overuse for what turn out to be viral infections is a persistent problem. Surveys of physicians have found that a large majority would prescribe antibiotics immediately for symptoms that do not meet guidelines for bacterial sinusitis, driven by patient expectations and diagnostic uncertainty.12Elsevier (Disease-a-Month). Cost burden of viral respiratory infections: Issues for formulary decision makers If your doctor prescribes cephalexin on day three of a cold with some facial pressure, the issue is probably not the drug choice. It is that an antibiotic was given at all before the clinical criteria for bacterial sinusitis were met.
Supportive Treatments That Help Regardless
Whether your sinus infection is viral or bacterial, and whether or not you take an antibiotic, a few treatments can make you feel better while your body fights the infection. Intranasal corticosteroid sprays have been studied extensively for acute sinusitis. A systematic review and meta-analysis found that they produce a small but real improvement in symptom resolution at around three weeks, with the most consistent benefits for facial pain and congestion.13The Annals of Family Medicine. Intranasal Corticosteroids in Management of Acute Sinusitis: A Systematic Review and Meta-Analysis A Cochrane review similarly supports intranasal steroids as either a standalone treatment or as an add-on to antibiotics.14PubMed Central. Intranasal steroids for acute sinusitis
The evidence is not uniformly strong, though. One randomized controlled trial found that neither amoxicillin nor topical budesonide (an intranasal steroid) significantly sped up symptom resolution compared to placebo, with roughly the same proportion of patients still symptomatic at 10 days regardless of treatment group.15JAMA. Antibiotics and Topical Nasal Steroid for Treatment of Acute Maxillary Sinusitis: A Randomized Controlled Trial This trial underscores the self-limited nature of many sinus infections and suggests that for milder cases, the body’s own immune response does most of the heavy lifting.
Beyond nasal steroid sprays, saline irrigation with a neti pot or squeeze bottle helps thin mucus and flush debris from the sinuses. Over-the-counter pain relievers like ibuprofen or acetaminophen address the headache and facial pain. Staying well-hydrated and using steam inhalation can also provide comfort, though the evidence for steam is mostly anecdotal.
When Undertreated Sinusitis Gets Dangerous
The concern with choosing an ineffective antibiotic is not just lingering symptoms. True bacterial sinusitis that fails to clear can, in rare cases, lead to serious complications. Because the sinuses sit directly adjacent to the eyes and the brain, untreated or inadequately treated infections can spread to those structures, causing orbital infections like preseptal or postseptal cellulitis, or intracranial infections including epidural and subdural abscesses.16PubMed. Complications of sinusitis These complications are uncommon, but they are the reason clinicians take bacterial sinusitis seriously once the diagnosis is reasonably established.
This is one of the stronger arguments against using cephalexin for a confirmed bacterial sinus infection. If the drug leaves gram-negative pathogens uncovered, you may appear to partially improve (as the gram-positive organisms respond) while the gram-negative component persists. You then might not seek further treatment until symptoms worsen significantly. Choosing an antibiotic with appropriate spectrum from the start reduces that risk.
Why Your Doctor Might Prescribe Cephalexin Anyway
Despite the guidelines, some doctors do prescribe cephalexin for sinus infections, and there are a few possible reasons. First, cephalexin is inexpensive and widely available, and the cost difference between it and a newer cephalosporin can matter for uninsured patients. Second, if a doctor suspects the infection is primarily caused by a gram-positive organism, perhaps based on culture results from a chronically draining sinus, cephalexin could be a targeted choice. Third, in the real world, not every prescription perfectly tracks the latest guideline, and older prescribing habits can persist.
If you find yourself holding a cephalexin prescription for a sinus infection, it is reasonable to ask your doctor whether amoxicillin-clavulanate or a second-generation cephalosporin like cefuroxime might be a better fit. Most doctors are perfectly comfortable having that conversation, and in many cases the choice was made quickly and could be reconsidered. If you have a penicillin allergy and your doctor chose cephalexin because it is a cephalosporin, it is worth noting that the cross-reactivity between penicillins and cephalosporins is much lower than once thought, and the specific cephalosporins recommended for sinusitis (cefuroxime, cefpodoxime, cefdinir) are the same drug class. If your allergy history allows any cephalosporin, switching to one of those broader-spectrum options is usually straightforward.
Side Effects Are Not the Issue
One thing cephalexin has going for it is tolerability. It is one of the best-tolerated antibiotics on the market, with a safety profile studied for decades. Research comparing cephalexin to amoxicillin-clavulanate in pregnant women, a population in which safety is watched closely, found no significant difference in side effect rates and no fetal toxicity attributable to either drug.17PubMed Central. Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy The most common side effects are mild gastrointestinal symptoms like nausea and diarrhea, which occur at similar rates across most oral antibiotics. So the argument against cephalexin for sinus infections is not about safety or side effects; it is strictly about whether the drug’s antibacterial coverage matches the bacteria causing the infection.
Where Cephalexin Actually Shines
Cephalexin remains an excellent antibiotic for many other common infections. Skin and soft tissue infections caused by staphylococci and streptococci, such as cellulitis and impetigo, respond well to it. Uncomplicated urinary tract infections, bone infections, and some dental infections also fall within its sweet spot. Its affordability, long safety track record, and effectiveness against gram-positive organisms make it one of the most frequently prescribed antibiotics worldwide. The fact that it is not ideal for sinus infections does not diminish its value elsewhere. It just reflects the reality that no single antibiotic covers every type of infection, and matching the drug to the likely pathogens is what makes antibiotic selection work.